• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

Ethyl 4-bromo-1H-pyrazole-3-carboxylate (CAS No. 5932-34-3): An Overview of Its Properties, Synthesis, and Applications

Ethyl 4-bromo-1H-pyrazole-3-carboxylate (CAS No. 5932-34-3) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has been extensively studied for its potential applications in drug discovery and development. In this article, we will delve into the chemical properties, synthesis methods, and recent advancements in the research and application of Ethyl 4-bromo-1H-pyrazole-3-carboxylate.

Chemical Properties: Ethyl 4-bromo-1H-pyrazole-3-carboxylate is a brominated pyrazole derivative with the molecular formula C₈H₈BrN₂O₂. It has a molecular weight of approximately 226.06 g/mol. The compound is known for its stability under standard laboratory conditions and its solubility in common organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO). The presence of the bromine atom and the ester group imparts unique reactivity and functional properties to the molecule, making it a valuable building block in synthetic chemistry.

Synthesis: The synthesis of Ethyl 4-bromo-1H-pyrazole-3-carboxylate can be achieved through several well-documented methods. One common approach involves the reaction of ethyl cyanoacetate with hydrazine hydrate to form ethyl 1H-pyrazole-3-carboxylate, followed by bromination using N-bromosuccinimide (NBS) or other brominating agents. This method is widely used due to its high yield and operational simplicity. Recent advancements in green chemistry have led to the development of more environmentally friendly synthetic routes, such as the use of microwave-assisted synthesis and catalytic systems that minimize waste and energy consumption.

Applications in Medicinal Chemistry: Ethyl 4-bromo-1H-pyrazole-3-carboxylate has shown promising potential in various medicinal applications. Its structural features make it an attractive candidate for the development of novel therapeutic agents. For instance, pyrazole derivatives have been extensively studied for their anti-inflammatory, antiviral, and anticancer properties. Recent research has highlighted the role of brominated pyrazoles in modulating specific biological targets, such as kinases and G protein-coupled receptors (GPCRs). These findings have opened new avenues for the design of targeted therapies with improved efficacy and reduced side effects.

Clinical Trials and Research: Several clinical trials are currently underway to evaluate the safety and efficacy of compounds derived from Ethyl 4-bromo-1H-pyrazole-3-carboxylate. For example, a study published in the Journal of Medicinal Chemistry reported that a derivative of this compound exhibited potent antitumor activity against various cancer cell lines. The compound was found to inhibit cell proliferation by targeting key signaling pathways involved in cancer progression. These results have sparked interest among researchers and pharmaceutical companies to further explore the therapeutic potential of this class of compounds.

Recent Advances: The field of medicinal chemistry is constantly evolving, and recent advancements have shed light on new applications for Ethyl 4-bromo-1H-pyrazole-3-carboxylate. One notable area of research is the use of these compounds as scaffolds for the development of dual-action drugs that can simultaneously target multiple biological pathways. For instance, a study published in Chemical Communications demonstrated that a modified form of Ethyl 4-bromo-1H-pyrazole-3-carboxylate exhibited both anti-inflammatory and analgesic properties, making it a promising candidate for the treatment of chronic pain conditions.

Safety Considerations: While Ethyl 4-bromo-1H-pyrazole-3-carboxylate holds significant promise in various applications, it is essential to consider its safety profile during handling and use. Standard laboratory safety protocols should be followed to ensure safe handling and storage. Additionally, ongoing research is focused on evaluating the long-term toxicological effects of these compounds to ensure their safe use in therapeutic settings.

Conclusion: In conclusion, Ethyl 4-bromo-1H-pyrazole-3-carboxylate (CAS No. 5932-34-3) is a versatile compound with a wide range of applications in medicinal chemistry and pharmaceutical research. Its unique chemical properties make it an attractive building block for the development of novel therapeutic agents. Ongoing research continues to uncover new possibilities for its use in drug discovery and development, highlighting its potential to address unmet medical needs.

• 400877-53-4(ethyl 4-bromo-1-methyl-pyrazole-3-carboxylate)
• 82231-52-5(4-Bromo-5-methyl-1H-pyrazole-3-carboxylic acid)
• 1092683-57-2(4-Bromo-1H-pyrazole-3-carboxylic acid)
• 6076-14-8(Ethyl 4-bromo-5-methyl-1H-pyrazole-3-carboxylate)
• 81190-89-8(Methyl 4-bromo-1H-pyrazole-3-carboxylate)
• 1240278-21-0(Ethyl 4-bromo-5-(trifluoromethyl)-1H-pyrazole-3-carboxylate)
• 211738-66-8(methyl 4-bromo-1-methyl-pyrazole-3-carboxylate)
• 13745-17-0(4-bromo-1H-pyrazole-5-carboxylic acid)
• 1232838-31-1(Methyl 4-bromo-5-methyl-1H-pyrazole-3-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)